![]() HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | |||
Founding Date | Founding Date 2020 | Founding Date 2011 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Boston, US HQ | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 31 | Employees 1561% increase | Employees 58 |
Valuation ($) | Valuation ($) 95.1 m | Valuation ($) 487.2 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($147.3m) (FY, 2024) | Net income ($115.2m) (FY, 2025) | Net income (£14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 217.5m | Total funding raised $ 66.8m |

AbSci is a company that provides generative AI drug-creation solutions.
View company
e-therapeutics is a computational drug discovery company.
View company